https://www.premera.com/medicalpolicies/5.01.612.pdf#search=policy
PHARMACY POLICY - 5.01.612 Pharmacologic Treatment of Cystinosis Effective Date: Nov. 1, ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.613.pdf#search=policy
PHARMACY POLICY - 5.01.613 Oral Iron Chelating Agents Effective Date: Jan. 1, 2023 Last ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.617.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.617 Folate Antimetabolites Effective Date: Jan. 1, 2023 ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.619.pdf#search=policy
MEDICAL POLICY - 5.01.619 Intravitreal and Suprachoroidal Corticosteroids Effective Date: ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.624.pdf#search=policy
MEDICAL POLICY - 5.01.624 Alpha-1 Proteinase Inhibitors Effective Date: Jan. 1, 2023 Last ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.629.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.629 Pharmacologic Treatment of Psoriasis Effective Date: ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/6.01.40.pdf#search=policy
MEDICAL POLICY - 6.01.40 Whole Body Dual X-Ray Absorptiometry to Determine Body Composition BCBSA Ref. Policy: 6.01.40 Effective Date: Jan. 1, 2023 Last Revised: Dec. 12, 2022 ...
https://www.premera.com/medicalpolicies/6.01.54.pdf#search=policy
MEDICAL POLICY - 6.01.54 Dopamine Transporter Imaging with Single-Photon Emission Computed Tomography BCBSA Ref. Policy: 6.01.54 Effective Date: Jan. 1, 2023 Last Revised: Dec. ...
https://www.premera.com/medicalpolicies/7.01.07.pdf#search=policy
MEDICAL POLICY - 7.01.07 Electrical Bone Growth Stimulation of the Appendicular Skeleton BCBSA Ref. Policy: 7.01.07 Effective Date: July 1, 2022 Last Revised: June 13, 2022 ...
https://www.premera.com/medicalpolicies/7.01.134.pdf#search=policy
MEDICAL POLICY - 7.01.134 Steroid-Eluting Sinus Stents and Implants BCBSA Ref. Policy: 7.01.134 Effective Date: May 1, 2022 Last Revised: April 11, 2022 Replaces: N/A RELATED ...
https://www.premera.com/medicalpolicies/7.01.158.pdf#search=policy
MEDICAL POLICY - 7.01.158 Balloon Dilation of the Eustachian Tube BCBSA Ref. Policy: 7.01.158 Effective Date: Dec. 1, 2022 Last Revised: Nov. 7, 2022 Replaces: N/A RELATED MEDICAL ...
https://www.premera.com/medicalpolicies/7.01.569.pdf#search=policy
MEDICAL POLICY - 7.01.569 Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions BCBSA Ref. Policy: 7.01.48 Effective Date: July 1, 2022 Last Revised: June 27, ...
https://www.premera.com/medicalpolicies/7.01.572.pdf#search=policy
MEDICAL POLICY - 7.01.572 Irreversible Electroporation (NanoKnife® System) Effective ... below to be directed to that section. POLICY CRITERIA | CODING | RELATED INFORMATION ...
https://www.premera.com/medicalpolicies/7.01.72.pdf#search=policy
POLICY - 7.01.72 Percutaneous Intradiscal Electrothermal Annuloplasty, Radiofrequency Annuloplasty, Biacuplasty,and Intraosseous Basivertebral Nerve Ablation BCBSA Ref. Policy: ...
https://www.premera.com/medicalpolicies/7.03.05.pdf#search=policy
MEDICAL POLICY - 7.03.05 Small Bowel, Liver and Multivisceral Transplant BCBSA Ref. Policy: 7.03.05, 7.03.14 Effective Date: Nov. 1, 2022 Last Revised: Oct. 10, 2022 Replaces: ...
https://www.premera.com/medicalpolicies/7.03.13.pdf#search=policy
MEDICAL POLICY - 7.03.13 Composite Tissue Allotransplantation of the Hand and Face BCBSA Ref. Policy: 7.03.13 Effective Date: Nov. 1, 2022 Last Revised: Oct. 24, 2022 Replaces: N/...
https://www.premera.com/medicalpolicies/8.01.42.pdf#search=policy
MEDICAL POLICY - 8.01.42 Hematopoietic Cell Transplantation for Primary Amyloidosis BCBSA Ref. Policy: 8.01.42 Effective Date: Apr. 1, 2022 Last Revised: Oct. 1, 2022 Replaces: ...
https://www.premera.com/medicalpolicies/8.01.533.pdf#search=policy
MEDICAL POLICY - 8.01.533 Radioimmunotherapy in the Treatment of Non-Hodgkin Lymphoma BCBSA Ref. Policy: 8.01.50 Effective Dec. 1, 2022 Last Revised: Nov. 7, 2022 Replaces: ...
https://www.premera.com/medicalpolicies/5.01.545.pdf#search=policy
PHARMACY POLICY - 5.01.545 Tadalafil Products for Benign Prostatic Hyperplasia Effective ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/1.01.29.pdf#search=policy
MEDICAL POLICY - 1.01.29 Tumor Treating Fields Therapy BCBSA Ref. Policy: 1.01.29 Effective Date: Oct. 1, 2022 Last Revised: Sept. 12, 2022 Replaces: N/A RELATED MEDICAL POLICIES: ...